Analysis of viable CD133+/CD34+AND CD34+stem cell subsets in prediction of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation.

被引：0
|
作者：
Hicks, C. [1 ]
机构：
[1] St George Hosp, Sydney, NSW, Australia
来源：
CYTOTHERAPY | 2006年 / 8卷
关键词：
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Factors predicting engraftment of autologous blood stem cells: CD34+ subsets inferior to the total CD34+ cell dose
    DA Stewart
    D Guo
    J Luider
    I Auer
    J Klassen
    E Ching
    D Morris
    A Chaudhry
    C Brown
    JA Russell
    [J]. Bone Marrow Transplantation, 1999, 23 : 1237 - 1243
  • [32] Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease
    Salama, Hosny
    Zekri, Abdel-Rahman N.
    Bahnassy, Abeer A.
    Medhat, Eman
    Halim, Hanan A.
    Ahmed, Ola S.
    Mohamed, Ghada
    Al Alim, Sheren A.
    Sherif, Ghada M.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (42) : 5297 - 5305
  • [33] The Effect of Age and CD34+Stem Cell Dose on Autologous Hematopoietic Stem Cell Transplantation Outcomes in Multiple Myeloma - Single Institution Experience
    Skousen, Madeline
    Holstein, Sarah A.
    Lunning, Matthew A.
    Lyden, Elizabeth R.
    Sheree, Gilmore
    Schmit-Pokorny, Kimberly
    Armitage, James O.
    Al-Kadhimi, Zaid S.
    Vose, Julie M.
    Baljevic, Muhamed
    [J]. BLOOD, 2019, 134
  • [34] CD34+ and CD133+ Primitive Stem Cell Expression in Peripheral Blood: Considering Gender, Age, and Smoking
    Reichelt, Heike
    Barz, Dagmar
    Thude, Hansjoerg
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2009, 36 (02) : 129 - 134
  • [35] Autologous CD34+ selected peripheral stem cell transplantation (ASCT/CD34+) for multiple sclerosis (MS).
    Carreras, E
    Saiz, A
    Graus, F
    Marín, P
    Urbano-Ispizua, A
    Mercader, JM
    Martínez, C
    Rovira, M
    Mazzara, R
    Merino, A
    Tolosa, E
    Montserrat, E
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 : S33 - S33
  • [36] CD34+selected autologous peripheral blood stem cell transplantation in neuroblastoma
    Ahn, HS
    Kang, HJ
    Choi, HS
    Shin, HY
    [J]. BONE MARROW TRANSPLANTATION, 2004, 33 : S226 - S226
  • [37] CD34+/CD110+and CD34+/CD133+cells in the apheresis collections of multiple myeloma patients predict early and long-term haematopoietic recovery after peripheral blood stem cell transplantation
    Bruno, A.
    Velotta, V.
    Siniscalchi, A.
    Tendas, A.
    De Meis, I.
    Cantoni, F.
    Cupelli, L.
    Dentamaro, T.
    Del Poeta, G.
    Ballatore, G.
    Tamburini, A.
    Suppo, G.
    Del Proposto, G.
    Adorno, G.
    Amadori, S.
    De Fabritiis, P.
    Caravita, T.
    [J]. BONE MARROW TRANSPLANTATION, 2011, 46 : S63 - S63
  • [38] A comparison of CD34+ cell selected and unselected autologous peripheral blood stem cell transplantation for multiple myeloma:: a case controlled analysis
    Gandhi, MK
    Jestice, HK
    Scott, MA
    Bloxham, DM
    Bass, G
    Craig, JIO
    Marcus, RE
    [J]. BONE MARROW TRANSPLANTATION, 1999, 24 (04) : 369 - 375
  • [39] A comparison of CD34+ cell selected and unselected autologous peripheral blood stem cell transplantation for multiple myeloma: a case controlled analysis
    MK Gandhi
    HK Jestice
    MA Scott
    DM Bloxham
    G Bass
    JIO Craig
    RE Marcus
    [J]. Bone Marrow Transplantation, 1999, 24 : 369 - 375
  • [40] The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation
    Ilhan, O
    Arslan, Ö
    Arat, M
    Beksaç, M
    Akan, H
    Özcan, M
    Gürman, G
    Konuk, N
    Uysal, A
    Koç, H
    [J]. TRANSFUSION SCIENCE, 1999, 20 (01): : 69 - 71
12345